Florida Cannabis Policy Update: Medical Program Adjustments and Adult-Use Setback

Executive Summary

Florida’s cannabis market remains one of the largest medical-only markets in the U.S., but recent developments highlight a mixed trajectory. Over the past 30 days, lawmakers have advanced legislation to expand medical access, specifically reducing patient costs for veterans via HB 887, while adult-use legalization efforts have faced setbacks and are no longer expected to advance in 2026. For investors and operators, Florida remains a high-value but tightly controlled medical market, with future adult-use expansion still uncertain.

Florida continues to operate as a mature but evolving medical cannabis market, with policy activity reflecting both incremental reform and stalled broader legalization efforts. Recent legislative movement has focused on improving access within the existing medical framework, while parallel efforts to expand into adult-use have encountered structural and procedural challenges. For stakeholders, Florida remains a significant revenue market today, but one where long-term expansion depends on future voter and legislative alignment.

Current Legal Status

Florida maintains a regulated medical cannabis program supported by constitutional amendment and state statute. The state currently allows:

• Medical cannabis use for approximately 931,959 qualified patients with active ID cards.
• Vertically integrated licensed operators (Medical Marijuana Treatment Centers).
• Regulated cultivation, processing, and dispensing through 733 currently operating dispensaries.

However, adult-use cannabis remains illegal, and there is no approved framework for recreational sales at this time. Florida’s model continues to emphasize limited licensing and vertical integration, making it one of the more controlled large-scale markets in the U.S.

Recent Policy Activity

Over the past 30 days, legislative efforts have centered on medical program adjustments rather than expansion into adult-use. Key developments include:

• Advancement of HB 887/SB 1032: Legislation to reduce medical cannabis registration fees for honorably discharged veterans from $75 to $15.
• Legislative Progress: HB 887 cleared the House Health & Human Services Committee in late February 2026 with a unanimous vote.
• New Compliance Deadlines: Operators must comply with Rule 64ER25-6 by March 31, 2026, which mandates the removal of all “recreational-style” or “lifestyle” marketing.

If enacted, the fee change would take effect on July 1, 2026, lowering barriers to entry for veterans providing proof via a DD-214 or retired military ID. This type of reform reflects a continued trend in Florida: incremental expansion of access within a tightly regulated structure.

Adult-Use Legalization Status

While Florida has been viewed as a potential candidate for adult-use legalization, recent developments indicate no immediate pathway forward in 2026. Key updates include:

• Failure to Qualify: The “Smart & Safe Florida” campaign failed to reach the required 880,062 verified signatures by the February deadline.
• The Shortfall: The state verified only 783,592 signatures, despite the campaign submitting over 1.4 million total petitions.
• Judicial Status: While legal challenges regarding roughly 71,000 invalidated signatures continue in the state Supreme Court, the initiative is officially off the 2026 ballot.

As a result, Florida is no longer considered an active legalization state for the current election cycle. This marks a notable shift from prior expectations, where Florida had been viewed as a likely candidate for near-term transition.

Market Context: A Large but Controlled Medical System

Despite the lack of adult-use expansion, Florida remains one of the largest medical cannabis markets in the country. The state’s framework is characterized by:

• A vertically integrated licensing structure.
• A limited number of licensed operators, though 22 new licenses are anticipated for release in Summer 2026 following previous delays.
• Strong regulatory oversight through the Office of Medical Marijuana Use.

The Bottom Line

While lawmakers are advancing targeted improvements like HB 887 within the medical program, adult-use legalization is not expected in the near term following the failure of the 2026 ballot initiative. Furthermore, the March 31, 2026, marketing deadline signals that regulators are doubling down on the “medical-only” aesthetic of the market.

About Cannabis Business Advisors

For operators, investors, and entrepreneurs navigating cannabis policy and emerging markets, understanding how regulatory developments translate into operational strategy is critical.

Cannabis Business Advisors (CBA) tracks legislative developments, regulatory changes, and market dynamics across the United States to help industry leaders make informed decisions in a rapidly evolving industry. If you are evaluating opportunities in Florida’s cannabis market or want to discuss how recent regulatory shifts could impact market entry and compliance strategy, contact us at 602-290-9424 for additional insights.

This article is part of CBA’s ongoing state policy intelligence series tracking regulatory developments across emerging cannabis markets.

The Cannabis Business Advisors have more than thirty years of combined industry experience, spanning across the U.S. and around the globe. C.B. Advisors offers a comprehensive suite of services, including application and licensing preparation, operational analysis, merger and acquisition support, policy and procedures, exit strategy guidance, and business development planning. Stay up to date on the latest cannabis news with The CB Advisors!

Contact Info@thecannabisbusinessadvisors.com for more information on how to apply for a cannabis business license.